FDA OKs Abbott Zika Virus Detection Molecular Test that Involves Whole Blood Usage
The Food and Drug Administration has expanded its emergency use authorization for an Abbott-developed molecular test for Zika virus detection to involve the use of whole blood in addition to previous serum and urine sample usage. Abbott said Thursday the RealTime ZIKA test was created for use on the company’s molecular diagnostics instrument called the m2000 RealTime […] More